Jane Street’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-22,999
| Closed | -$229K | – | 11269 |
|
|
2025
Q2 | $229K | Buy |
22,999
+1,561
| +7% | +$12.6K | ﹤0.01% | 8329 |
|
|
2025
Q1 | $128K | Sell |
21,438
-113,593
| -84% | -$834K | ﹤0.01% | 8693 |
|
|
2024
Q4 | $1.04M | Buy |
135,031
+116,184
| +616% | +$998K | ﹤0.01% | 5315 |
|
|
2024
Q3 | $192K | Sell |
18,847
-141,008
| -88% | -$2.15M | ﹤0.01% | 8669 |
|
|
2024
Q2 | $2.37M | Buy |
+159,855
| New | +$2.29M | ﹤0.01% | 4202 |
|
|
2024
Q1 | – | Sell |
-23,933
| Closed | -$262K | – | 9633 |
|
|
2023
Q4 | $262K | Buy |
23,933
+12,990
| +119% | +$129K | ﹤0.01% | 7823 |
|
|
2023
Q3 | $120K | Sell |
10,943
-50,192
| -82% | -$642K | ﹤0.01% | 7878 |
|
|
2023
Q2 | $809K | Buy |
+61,135
| New | +$872K | ﹤0.01% | 5556 |
|
|
2023
Q1 | – | Sell |
-13,733
| Closed | -$268K | – | 9453 |
|
|
2022
Q4 | $268K | Sell |
13,733
-1,554
| -10% | -$30.4K | ﹤0.01% | 7209 |
|
|
2022
Q3 | $291K | Buy |
15,287
+2,884
| +23% | +$66.4K | ﹤0.01% | 7643 |
|
|
2022
Q2 | $256K | Buy |
12,403
+3,519
| +40% | +$83.5K | ﹤0.01% | 7843 |
|
|
2022
Q1 | $286K | Sell |
8,884
-5,969
| -40% | -$217K | ﹤0.01% | 8467 |
|
|
2021
Q4 | $692K | Buy |
+14,853
| New | +$494K | ﹤0.01% | 6658 |
|
|
2021
Q2 | – | Sell |
-11,148
| Closed | -$381K | – | 10084 |
|
|
2021
Q1 | $381K | Buy |
+11,148
| New | +$403K | ﹤0.01% | 7304 |
|
Other funds holding ITOS
Jane Street's ITOS Position: Q3 2025 in Review
Jane Street sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 22,999 shares — an estimated $229K sold.
Jane Street first reported a position in ITOS in Q1 2021 and held it in 14 quarters. The position peaked at $2.37M in Q2 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Jane Street reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 22,999 iTeos Therapeutics shares in Q3 2025, an estimated $229K.
- Jane Street first reported a position in iTeos Therapeutics in Q1 2021 and held it in 14 quarters.
- Jane Street's iTeos Therapeutics position peaked at $2.37M in Q2 2024.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.